Menu
GeneBe

SPTB

spectrin beta, erythrocytic, the group of Spectrins|Pleckstrin homology domain containing|MicroRNA protein coding host genes

Basic information

Region (hg38): 14:64746282-64879907

Links

ENSG00000070182NCBI:6710OMIM:182870HGNC:11274Uniprot:P11277AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary spherocytosis type 2 (Strong), mode of inheritance: AD
  • hereditary spherocytosis (Supportive), mode of inheritance: AD
  • hereditary elliptocytosis (Supportive), mode of inheritance: AD
  • elliptocytosis 3 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spherocytosis, type 2; Ellipsocytosis 3AD/ARHematologicSome individuals may have severe, transfusion-requiring anemia, and splenectomy may also be beneficialHematologic4426130; 7229027; 7119110; 7104494; 4052329; 3276733; 2807277; 2346784; 2070088; 1391962; 8102379; 8226774; 7883966; 8675627; 8844207; 9075575; 9005995; 9163587; 9414314; 9450796; 9609518; 9887280; 11703334; 19538529

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPTB gene.

  • not provided (639 variants)
  • Spherocytosis, Dominant (128 variants)
  • Elliptocytosis (128 variants)
  • Inborn genetic diseases (116 variants)
  • Hereditary spherocytosis type 2 (99 variants)
  • not specified (63 variants)
  • SPTB-related condition (16 variants)
  • Elliptocytosis 3 (11 variants)
  • Elliptocytosis 3;Hereditary spherocytosis type 2 (4 variants)
  • Hereditary spherocytosis (3 variants)
  • Familial hemolytic anemia (3 variants)
  • Spherocytosis;Hereditary spherocytosis;Elliptocytosis 3 (1 variants)
  • See cases (1 variants)
  • Pyropoikilocytosis, hereditary (1 variants)
  • Hemolytic anemia (1 variants)
  • Spherocytosis (1 variants)
  • ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPTB gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
13
clinvar
54
clinvar
14
clinvar
81
missense
1
clinvar
8
clinvar
319
clinvar
16
clinvar
3
clinvar
347
nonsense
52
clinvar
58
clinvar
110
start loss
1
clinvar
1
clinvar
2
frameshift
39
clinvar
67
clinvar
106
inframe indel
8
clinvar
8
splice donor/acceptor (+/-2bp)
8
clinvar
23
clinvar
31
splice region
1
22
13
2
38
non coding
13
clinvar
17
clinvar
35
clinvar
65
Total 100 157 354 87 52

Highest pathogenic variant AF is 0.0000788

Variants in SPTB

This is a list of pathogenic ClinVar variants found in the SPTB region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-64749356-C-T Uncertain significance (Dec 28, 2023)2436418
14-64749368-C-T Inborn genetic diseases • Hereditary spherocytosis type 2 Uncertain significance (Sep 26, 2023)3169525
14-64749402-C-T not specified Benign (Nov 22, 2023)257137
14-64749413-G-C Inborn genetic diseases Uncertain significance (Aug 17, 2021)2246463
14-64749427-T-G Inborn genetic diseases Uncertain significance (May 08, 2023)2508931
14-64749428-C-T Uncertain significance (Jan 06, 2020)1163362
14-64749447-G-A SPTB-related disorder Benign (May 01, 2020)994335
14-64749462-C-T SPTB-related disorder Likely benign (Sep 20, 2021)3059908
14-64749480-G-A Uncertain significance (Nov 30, 2020)1163363
14-64749638-G-C Likely benign (Mar 31, 2022)2428689
14-64749997-GCTT-G Conflicting classifications of pathogenicity (Dec 20, 2023)2436443
14-64750000-T-G Inborn genetic diseases Uncertain significance (Apr 07, 2023)2507704
14-64750020-G-A Familial hemolytic anemia Uncertain significance (Feb 27, 2018)544815
14-64750023-A-G Inborn genetic diseases Uncertain significance (Mar 21, 2023)2524717
14-64750030-A-AGAT Uncertain significance (Aug 18, 2023)2921196
14-64750041-C-T not specified Uncertain significance (Mar 22, 2024)3233797
14-64750051-G-T Familial hemolytic anemia Uncertain significance (Feb 27, 2018)544814
14-64750130-C-G Uncertain significance (Nov 09, 2023)2690138
14-64753574-G-A Inborn genetic diseases Uncertain significance (Feb 01, 2023)2473820
14-64753580-G-A Inborn genetic diseases Uncertain significance (Jan 18, 2022)2271992
14-64753597-A-C Inborn genetic diseases Uncertain significance (Jan 24, 2024)3169523
14-64753601-GCA-G Hereditary spherocytosis type 2 Pathogenic (Mar 01, 2022)1676979
14-64753621-C-G Inborn genetic diseases • SPTB-related disorder Conflicting classifications of pathogenicity (Apr 10, 2023)2560857
14-64753621-C-T Inborn genetic diseases Uncertain significance (Jan 24, 2023)2462760
14-64753630-G-A Uncertain significance (Aug 02, 2022)2436452

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPTBprotein_codingprotein_codingENST00000389722 35133600
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.002.95e-121257020461257480.000183
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.75112781.36e+30.9430.000093915320
Missense in Polyphen426501.120.85015895
Synonymous-2.286575871.120.00004144464
Loss of Function9.0391120.08020.000005741250

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001480.000148
Ashkenazi Jewish0.000.00
East Asian0.001530.00147
Finnish0.00004620.0000462
European (Non-Finnish)0.00007080.0000703
Middle Eastern0.001530.00147
South Asian0.0001960.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane.;
Disease
DISEASE: Elliptocytosis 3 (EL3) [MIM:617948]: A Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous hematologic disorder characterized by variable hemolytic anemia and elliptical or oval red cell shape. Inheritance can be autosomal dominant or autosomal recessive. {ECO:0000269|PubMed:1975598, ECO:0000269|PubMed:7883966, ECO:0000269|PubMed:8018926, ECO:0000269|PubMed:8226774}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 2 (SPH2) [MIM:616649]: An autosomal dominant form of hereditary spherocytosis, a group of hematologic disorders characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Clinical manifestations include chronic hemolytic anemia, jaundice, and splenomegaly, with variable severity. {ECO:0000269|PubMed:19538529, ECO:0000269|PubMed:8102379}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Developmental Biology;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Interaction between L1 and Ankyrins;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;NCAM signaling for neurite out-growth;L1CAM interactions;COPI-mediated anterograde transport;Axon guidance;ER to Golgi Anterograde Transport (Consensus)

Recessive Scores

pRec
0.330

Intolerance Scores

loftool
0.144
rvis_EVS
-2.64
rvis_percentile_EVS
0.78

Haploinsufficiency Scores

pHI
0.313
hipred
Y
hipred_score
0.793
ghis
0.557

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.853

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Sptb
Phenotype
reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
sptb
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
teardrop-shaped

Gene ontology

Biological process
MAPK cascade;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;axon guidance;actin filament capping
Cellular component
Golgi apparatus;cytosol;spectrin;spectrin-associated cytoskeleton;actin cytoskeleton;intrinsic component of the cytoplasmic side of the plasma membrane;protein-containing complex
Molecular function
actin binding;Ras guanyl-nucleotide exchange factor activity;structural constituent of cytoskeleton;protein binding;ankyrin binding;actin filament binding